Foley Attorneys Publish on Telemedicine Considerations for Decentralized Clinical Trials
January 14, 2025
Applied Clinical Trials
Foley & Lardner LLP attorneys Jessica Warwick, Kyle Faget, and Monica Chmielewski authored the Applied Clinical Trials article, “Telemedicine Considerations When Conducting Decentralized Clinical Trials.”
“Decentralized clinical trials (DCTs) involve some or all trial-related activities conducted at locations other than traditional clinical trial sites, such as via telemedicine or in a clinical trial participant’s home,” the authors write. “The use of telemedicine in DCTs implicates various state legal and regulatory considerations as the performance of research, or the performance of certain procedures within a clinical trial, may and often fall within and are deemed to be the ‘practice of medicine.'”
Related News
June 2, 2026
In the News
Natasha Allen Authors Article on the Sectors Shaping America’s Next Economic Era
Foley & Lardner LLP partner Natasha Allen authored the Law.com article, “The Next 250: Which Sectors Will Define America’s Second Quarter-Millennium?” examining the industries poised to shape America’s next era and the legal and regulatory challenges accompanying their rapid growth.
June 2, 2026
In the News
Christopher McKenna Highlighted in Massachusetts Managing Partner Spotlight
Foley & Lardner LLP partner Christopher McKenna is featured in a Managing Partner Spotlight by Massachusetts Lawyers Weekly for his distinct leadership role and commitment to firm’s Boston office.
June 1, 2026
In the News
Gregory Husisian Analyzes U.S.–Taiwan Tariff Agreement and Trade Strategy Shifts
Foley & Lardner LLP partner Gregory Husisian is quoted in the Supply Chain Dive article, “US sets Taiwan tariffs at 15% on auto parts, wood, aircraft parts,” discussing the U.S.–Taiwan trade and investment agreement.